Nordic Life Science 1
What science can do AstraZeneca is a global, scie
nce-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas – Oncology, Cardiovascular, Renal & Metabolic diseases and Respiratory. Our footprint in the Nordics is significant, especially in Sweden where 6,900 people are working to deliver life changing medicines to patients. The company has sites in Gothenburg and Södertälje, where we are continuously looking for skilled talents. Either you are interested in working with R&D, marketing, manufacturing, enabling functions or you would like to become part of our new highly technological plant for biologics in Södertälje, you should look out for vacancies at www.astrazeneca.se/karriar Pancreatic beta cells at different stages of regeneration AstraZeneca is conducting research to find medicines that could stimulate the proliferation of beta cells in the pancreas, or induce the differentiation of other cells into insulin producing beta cells. Our ambition with this research is to hopefully one day be able to stop the progression or maybe even reverse the course of diabetes. AstraZeneca 151 85 Södertälje www.astrazeneca.se SE-3847-09-18-AZ